Yot Teerawattananon

Yot Teerawattananon is the founder and a Senior Researcher at the Health Intervention and Technology Assessment Program (HITAP), a semi-autonomous research institute of Thailand's Ministry of Public Health. The works of HITAP have been used to inform policy decisions regarding the adoption of medicines, medical devices, health promotion and disease prevention programmes under the Universal Health Coverage Scheme and the national pharmaceutical reimbursement list, the National List of Essential Medicines. 

Yot has gone on to provide technical advice to many national and international agencies, including the Gates Foundation, World Health Organization, World Bank, Asian Development Bank, and the Centre for Global Development (CGD), giving him a broad knowledge of key issues in global health. He is also one of the founders of HTAsiaLink, a regional network comprising of governmental health technology assessment agencies in South Korea, Japan, China, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Bhutan, and Thailand.

A health worker prepares a dose of AstraZeneca COVID-19 vaccine at the Central Vaccination Center inside the Bang Sue Grand Station (railway station), in Bangkok, Thailand, on June 21, 2021.
Governance

The Question of Booster Vaccines in Low- and Middle-Income Countries

by Saudamini V. Dabak, Dian Faradiba, Myka Harun Sarajan, Jirathorn Sutawong, Yot Teerawattananon, Wanrudee Isaranuwatchai 

High-income nations aren't the only ones seeking the COVID-19 vaccine "holy grail"